![Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting - PR Newswire APAC Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting - PR Newswire APAC](https://mma.prnasia.com/media2/1794036/image_5002937_41620453.jpg?p=medium600)
Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting - PR Newswire APAC
![AACR 2017 | Poster 3939/6 – two evolutionary models proposed for development of drug resistance between primary and relapsed Diffuse Large B-Cell Lymphoma AACR 2017 | Poster 3939/6 – two evolutionary models proposed for development of drug resistance between primary and relapsed Diffuse Large B-Cell Lymphoma](https://lymphomahub.com/media/images/94/8d/thumb-3395-pagebody-body2x.jpeg)
AACR 2017 | Poster 3939/6 – two evolutionary models proposed for development of drug resistance between primary and relapsed Diffuse Large B-Cell Lymphoma
![Poster #5915: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue - ClearLight Biotechnologies Poster #5915: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue - ClearLight Biotechnologies](https://clearlightbiotechnologies.com/wp-content/uploads/2018/09/AACR-2017-poster-scaled.jpg)
Poster #5915: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue - ClearLight Biotechnologies
![Immunological characterization of the Oncopig model and detection of cell-mediated immune responses to cancer | Comparative Genomics Immunological characterization of the Oncopig model and detection of cell-mediated immune responses to cancer | Comparative Genomics](https://comparativegenomics.illinois.edu/sites/comparativegenomics.illinois.edu/files/styles/large/public/2017%20overgarrd%20AACR%20poster.jpg?itok=i9FCnafR)
Immunological characterization of the Oncopig model and detection of cell-mediated immune responses to cancer | Comparative Genomics
![AACR 2017: Allosteric inhibition of the Receptor Tyrosine Kinases c-MET, RON and VEGFR-2 via the co-receptor CD44v6 by the novel compound AMC303 – amcure AACR 2017: Allosteric inhibition of the Receptor Tyrosine Kinases c-MET, RON and VEGFR-2 via the co-receptor CD44v6 by the novel compound AMC303 – amcure](https://amcure.com/wp-content/uploads/2019/06/AACR-Poster-4911.jpg)
AACR 2017: Allosteric inhibition of the Receptor Tyrosine Kinases c-MET, RON and VEGFR-2 via the co-receptor CD44v6 by the novel compound AMC303 – amcure
![AACR 2017 | Poster CT038/14 – 204653 study design: a phase I, open-label, dose-escalation study of GSK3326595 in patients with Non-Hodgkin Lymphoma AACR 2017 | Poster CT038/14 – 204653 study design: a phase I, open-label, dose-escalation study of GSK3326595 in patients with Non-Hodgkin Lymphoma](https://lymphomahub.com/media/images/05/52/thumb-3361-pagebody-body2x.jpeg)
AACR 2017 | Poster CT038/14 – 204653 study design: a phase I, open-label, dose-escalation study of GSK3326595 in patients with Non-Hodgkin Lymphoma
![AACR 2017 | Poster 2657/16 – PD-L1 blockade enhances T-cell cytotoxicity against Primary Mediastinal B-Cell Lymphoma AACR 2017 | Poster 2657/16 – PD-L1 blockade enhances T-cell cytotoxicity against Primary Mediastinal B-Cell Lymphoma](https://lymphomahub.com/media/images/33/f1/thumb-3382-pagebody-body2x.jpeg)
AACR 2017 | Poster 2657/16 – PD-L1 blockade enhances T-cell cytotoxicity against Primary Mediastinal B-Cell Lymphoma
![AACR 2017 | Poster 4295/4 – AZ'5576 demonstrates in vitro and in vivo activity in preclinical models of ABC Diffuse Large B-Cell Lymphoma AACR 2017 | Poster 4295/4 – AZ'5576 demonstrates in vitro and in vivo activity in preclinical models of ABC Diffuse Large B-Cell Lymphoma](https://lymphomahub.com/media/images/29/1a/thumb-3412-pagebody-body2x.jpeg)
AACR 2017 | Poster 4295/4 – AZ'5576 demonstrates in vitro and in vivo activity in preclinical models of ABC Diffuse Large B-Cell Lymphoma
![Evaluation of ETS2101 in Combination with anti-mCTLA4 Monoclonal Antibody on CD4 and CD8 TILs in a Subcutaneous CT-26 Colorectal Cancer Model - OracleBio Evaluation of ETS2101 in Combination with anti-mCTLA4 Monoclonal Antibody on CD4 and CD8 TILs in a Subcutaneous CT-26 Colorectal Cancer Model - OracleBio](https://oraclebio.com/wp-content/uploads/2020/08/E-therapeutics_OracleBio-poster_AACR2017_DPH1_VF_3_vf-scaled.jpg)
Evaluation of ETS2101 in Combination with anti-mCTLA4 Monoclonal Antibody on CD4 and CD8 TILs in a Subcutaneous CT-26 Colorectal Cancer Model - OracleBio
![Annual Meeting 2022: Undergraduate Students Get the Scoop from Early-career Researchers - American Association for Cancer Research (AACR) Annual Meeting 2022: Undergraduate Students Get the Scoop from Early-career Researchers - American Association for Cancer Research (AACR)](https://www.aacr.org/wp-content/uploads/2022/04/Feature_600x450_22AM_2103030Aa_1-1-500x350-2.jpg)
Annual Meeting 2022: Undergraduate Students Get the Scoop from Early-career Researchers - American Association for Cancer Research (AACR)
![AACR 2017 | Poster 1318/19 – Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma genome-wide association study finds an association with chromosomes 6 and 14 AACR 2017 | Poster 1318/19 – Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma genome-wide association study finds an association with chromosomes 6 and 14](https://lymphomahub.com/media/images/37/0e/thumb-3374-pagebody-body2x.jpeg)
AACR 2017 | Poster 1318/19 – Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma genome-wide association study finds an association with chromosomes 6 and 14
![AACR 2017 | Poster 2033/5 – Testing the combined effects of low dose olaparib plus ibrutinib on Mantle Cell Lymphoma cytotoxicity AACR 2017 | Poster 2033/5 – Testing the combined effects of low dose olaparib plus ibrutinib on Mantle Cell Lymphoma cytotoxicity](https://lymphomahub.com/media/images/4c/2f/thumb-3387-pagebody-body2x.jpeg)